ZYVOX

This brand name is authorized in United States. It is also authorized in Brazil, Ecuador, Hong Kong SAR China, Ireland, Japan, Malta, New Zealand, Singapore, UK.

Active ingredients

The drug ZYVOX contains one active pharmaceutical ingredient (API):

1	Linezolid UNII ISQ9I6J12J - LINEZOLID
	Linezolid is a synthetic, antibacterial agent that belongs to a new class of antimicrobials, the oxazolidinones. It has in vitro activity against aerobic Gram-positive bacteria and anaerobic micro-organisms. Linezolid selectively inhibits bacterial protein synthesis via a unique mechanism of action.
	Read more about Linezolid

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ZYVOX Solution for injection	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01XX08	Linezolid	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01X Other antibacterials → J01XX Other antibacterials
Discover more medicines within J01XX08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	522718080081617, 522718080081717
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	23.641-1-04-11, 548-MEE-1214
GB	Medicines & Healthcare Products Regulatory Agency	44504, 48274, 49470
HK	Department of Health Drug Office	48055, 48056, 48057
IE	Health Products Regulatory Authority	88361, 88362
JP	医薬品医療機器総合機構	6249002F1024, 6249401A1025
MT	Medicines Authority	MA505/01802, MA505/01803
NZ	Medicines and Medical Devices Safety Authority	9578, 9579, 9581
SG	Health Sciences Authority	11405P, 11407P, 11408P
US	FDA, National Drug Code	0009-4992, 0009-5136, 0009-5137, 0009-5138, 0009-5140, 0009-7807, 66298-4992, 66298-5137, 66298-5140, 66298-7807, 70518-1226